Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials

Norman Latov; Thomas H. Brannagan; Howard W. Sander; Francisco de Assis Aquino Gondim

doi:10.1055/s-0043-1777728

Arquivos de Neuro-Psiquiatria (Jun 2024)

Anti-MAG neuropathy: historical aspects, clinical-pathological correlations, and considerations for future therapeutical trials

Norman Latov,
Thomas H. Brannagan,
Howard W. Sander,
Francisco de Assis Aquino Gondim

Affiliations

Norman Latov: ORCiD; Weil Medical College of Cornell University, Peripheral Neuropathy Center, New York, New York, United States.
Thomas H. Brannagan: ORCiD; Columbia University, Vagelos College of Physicians and Surgeons, Peripheral Neuropathy Center, Department of Neurology, New York, New York, United States.
Howard W. Sander: ORCiD; New York University, Department of Neurology, New York, New York, United States.
Francisco de Assis Aquino Gondim: ORCiD; Universidade Federal do Ceará, Departamento de Medicina Clínica, Serviço de Neurologia, Fortaleza CE, Brazil.

DOI: https://doi.org/10.1055/s-0043-1777728
Journal volume & issue: Vol. 82, no. 06
pp. 001 – 007

Abstract

Read online

Background Patients with anti-MAG neuropathy present with distal demyelinating polyneuropathy, IgM monoclonal gammopathy, and elevated titers of anti-MAG antibodies.

Published in Arquivos de Neuro-Psiquiatria

ISSN: 0004-282X (Print); 1678-4227 (Online)
Publisher: Academia Brasileira de Neurologia (ABNEURO)
Country of publisher: Brazil
LCC subjects: Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry
Website: https://www.scielo.br/j/anp/

About the journal

Abstract

Keywords